|
US5906936A
(en)
|
1988-05-04 |
1999-05-25 |
Yeda Research And Development Co. Ltd. |
Endowing lymphocytes with antibody specificity
|
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
ATE452975T1
(de)
|
1992-08-21 |
2010-01-15 |
Univ Bruxelles |
Immunoglobuline ohne leichte ketten
|
|
US5830755A
(en)
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
|
US5840839A
(en)
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
EP0929318B1
(en)
|
1996-08-16 |
2004-11-24 |
The Johns Hopkins University School Of Medicine |
Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same
|
|
AU743855B2
(en)
|
1996-10-11 |
2002-02-07 |
Regents Of The University Of California, The |
Cancer immunotherapy using tumor cells combined with mixed lymphocytes
|
|
CA2304168A1
(en)
|
1997-09-19 |
1999-04-01 |
The Trustees Of The University Of Pennsylvania |
Methods and cell line useful for production of recombinant adeno-associated viruses
|
|
US6491907B1
(en)
*
|
1998-11-10 |
2002-12-10 |
The University Of North Carolina At Chapel Hill |
Recombinant parvovirus vectors and method of making
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
EP1147209A2
(en)
|
1999-02-03 |
2001-10-24 |
The Children's Medical Center Corporation |
Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
|
|
WO2001055393A2
(en)
|
2000-01-28 |
2001-08-02 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
|
|
JP2003526377A
(ja)
*
|
2000-03-14 |
2003-09-09 |
ニユーロロジクス・インコーポレーテツド |
キメラキャプシドベクターの製造
|
|
CA2425194A1
(en)
|
2000-10-09 |
2002-04-18 |
Andrew Nash |
Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal
|
|
US8716022B2
(en)
|
2000-11-17 |
2014-05-06 |
Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food |
Modulation of meiotic recombination
|
|
US7723111B2
(en)
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
|
DE60203125T2
(de)
|
2001-08-31 |
2006-04-06 |
Avidex Ltd., Abingdon |
Löslicher t zell rezeptor
|
|
WO2003067221A2
(en)
|
2002-02-08 |
2003-08-14 |
Xcyte Therapies, Inc. |
Compositions and methods for restoring immune responsiveness in patients with immunological defects
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
EP1517992B1
(en)
|
2002-06-05 |
2013-08-21 |
Her Majesty the Queen in Right of Canada, as represented by the Minister of Agriculture and Agri-Food |
Retrons for gene targeting
|
|
ES2874298T3
(es)
*
|
2003-09-30 |
2021-11-04 |
Univ Pennsylvania |
Clados de virus adenoasociados (AAV), secuencias, vectores que contienen el mismo, y usos de los mismos
|
|
US7435596B2
(en)
|
2004-11-04 |
2008-10-14 |
St. Jude Children's Research Hospital, Inc. |
Modified cell line and method for expansion of NK cell
|
|
WO2005113595A2
(en)
|
2004-05-19 |
2005-12-01 |
Avidex Ltd |
High affinity ny-eso t cell receptor
|
|
CA2567349C
(en)
|
2004-05-19 |
2012-11-27 |
Avidex Ltd |
Method of improving t cell receptors
|
|
CA2574572A1
(en)
|
2004-07-19 |
2006-10-26 |
Baylor College Of Medicine |
Modulation of cytokine signaling regulators and applications for immunotherapy
|
|
EP1828390B1
(en)
*
|
2004-12-15 |
2012-06-13 |
The University Of North Carolina At Chapel Hill |
Chimeric vectors
|
|
US8889365B2
(en)
|
2005-03-16 |
2014-11-18 |
Rutgers, The State University Of New Jersey |
Methods and kit for detecting breast cancer
|
|
ES2428218T3
(es)
*
|
2005-04-07 |
2013-11-06 |
The Trustees Of The University Of Pennsylvania |
Cápsides de AAV rh48 modificadas, composiciones que las contienen y usos de las mismas
|
|
US8283151B2
(en)
*
|
2005-04-29 |
2012-10-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
|
|
CA2612200A1
(en)
|
2005-06-15 |
2006-12-21 |
London Health Sciences Centre Research Inc. |
Method of cancer treatment using sirna silencing
|
|
DE602006017556D1
(de)
|
2005-08-05 |
2010-11-25 |
Helmholtz Zentrum Muenchen |
Erzeugung allorestriktiver spezifischer t-zellen
|
|
EP3284833B1
(en)
|
2005-08-26 |
2021-12-01 |
DuPont Nutrition Biosciences ApS |
Use of crispr associated genes (cas)
|
|
WO2007027509A2
(en)
|
2005-08-31 |
2007-03-08 |
Biogen Idec Ma Inc. |
Evaluating and treating scleroderma
|
|
WO2007089632A2
(en)
*
|
2006-01-27 |
2007-08-09 |
The University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
US9150882B2
(en)
*
|
2006-01-31 |
2015-10-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Self-complementary parvoviral vectors, and methods for making and using the same
|
|
KR101202498B1
(ko)
|
2006-05-17 |
2012-11-16 |
에프. 호프만-라 로슈 아게 |
폴리펩티드 생성 세포
|
|
US9816140B2
(en)
|
2006-05-19 |
2017-11-14 |
Dupont Nutrition Biosciences Aps |
Tagged microorganisms and methods of tagging
|
|
CN101511373B
(zh)
|
2006-06-19 |
2015-12-09 |
阿斯克肋匹奥生物制药公司 |
用于基因治疗的修饰的因子ⅷ和因子ⅸ基因和载体
|
|
EP1878744A1
(en)
|
2006-07-13 |
2008-01-16 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
|
|
US7750449B2
(en)
|
2007-03-13 |
2010-07-06 |
Micron Technology, Inc. |
Packaged semiconductor components having substantially rigid support members and methods of packaging semiconductor components
|
|
JP5840837B2
(ja)
|
2007-03-30 |
2016-01-06 |
メモリアル スローン−ケタリング キャンサー センター |
養子移入ｔリンパ球における副刺激リガンドの構成性発現
|
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
|
MX2010012592A
(es)
|
2008-05-20 |
2011-05-05 |
Eos Neuroscience Inc |
Vectores para la administracion de proteinas sensibles a la luz y metodos de uso de las mismas.
|
|
US8546553B2
(en)
|
2008-07-25 |
2013-10-01 |
University Of Georgia Research Foundation, Inc. |
Prokaryotic RNAi-like system and methods of use
|
|
WO2010025177A1
(en)
|
2008-08-26 |
2010-03-04 |
City Of Hope |
Method and compositions for enhanced anti-tumor effector functioning of t cells
|
|
US20100076057A1
(en)
|
2008-09-23 |
2010-03-25 |
Northwestern University |
TARGET DNA INTERFERENCE WITH crRNA
|
|
US9404098B2
(en)
|
2008-11-06 |
2016-08-02 |
University Of Georgia Research Foundation, Inc. |
Method for cleaving a target RNA using a Cas6 polypeptide
|
|
EP2396343B1
(en)
*
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
US9464119B2
(en)
|
2009-03-04 |
2016-10-11 |
Deutsches Krebsforschungszentrum |
Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3
|
|
EP2258719A1
(en)
|
2009-05-19 |
2010-12-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Multiple target T cell receptor
|
|
US20120192298A1
(en)
|
2009-07-24 |
2012-07-26 |
Sigma Aldrich Co. Llc |
Method for genome editing
|
|
US8383099B2
(en)
|
2009-08-28 |
2013-02-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adoptive cell therapy with young T cells
|
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
|
US9546112B2
(en)
*
|
2010-03-22 |
2017-01-17 |
Association Institut De Myologie |
Methods of increasing efficiency of vector penetration of target tissue
|
|
AR082925A1
(es)
|
2010-09-08 |
2013-01-16 |
Medigene Ag |
Proteinas estructurales mutadas por parvovirus con epitopo de celulas b de proteccion cruzada, producto y metodos relacionados
|
|
EP3467101A3
(en)
|
2010-09-08 |
2019-06-19 |
Baylor College of Medicine |
Immunotherapy of brain tumor using geneticially engineered gd2-specific t cells
|
|
US20140099284A1
(en)
|
2010-10-15 |
2014-04-10 |
Eos Neuroscience, Inc |
Modulation neural pathways
|
|
WO2012078540A1
(en)
|
2010-12-08 |
2012-06-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modulating immune cell activity using cytokine-induced src homology 2 and/or high temperature requirement a-1
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
WO2012112079A1
(en)
|
2011-02-14 |
2012-08-23 |
Vitaspero, Inc. |
IMPROVING CELLULAR IMMUNOTHERAPEUTIC VACCINES EFFICACY WITH GENE SUPPRESSION IN DENDRITIC CELLS AND T-LYMPHOCYTES USING SiRNA
|
|
US9528124B2
(en)
|
2013-08-27 |
2016-12-27 |
Recombinetics, Inc. |
Efficient non-meiotic allele introgression
|
|
MX359513B
(es)
|
2011-03-23 |
2018-10-01 |
Hutchinson Fred Cancer Res |
Metodo y composiciones para inmunoterapia celular.
|
|
US9610354B2
(en)
*
|
2011-04-18 |
2017-04-04 |
National Center Of Neurology And Psychiatry |
Drug delivery particle and method for producing the same
|
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
|
CN103732238A
(zh)
|
2011-06-08 |
2014-04-16 |
奥瑞基尼探索技术有限公司 |
用于免疫调节的治疗性化合物
|
|
KR101307196B1
(ko)
|
2011-07-15 |
2013-09-12 |
국립대학법인 울산과학기술대학교 산학협력단 |
미세 세포 배양 장치
|
|
WO2013040557A2
(en)
|
2011-09-16 |
2013-03-21 |
The Trustees Of The University Of Pennsylvania |
Rna engineered t cells for the treatment of cancer
|
|
US9593338B2
(en)
|
2011-09-28 |
2017-03-14 |
The Regents Of The University Of California |
Synthetic transcriptional control elements and methods of generating and using such elements
|
|
WO2013059725A1
(en)
|
2011-10-21 |
2013-04-25 |
Adaptive Biotechnologies Corporation |
Quantification of adaptive immune cell genomes in a complex mixture of cells
|
|
KR101471647B1
(ko)
|
2011-10-26 |
2014-12-11 |
국립암센터 |
변이 ｃｔｌａ4 유전자 이입 ｔ 세포 및 이를 포함하는 항암 면역치료용 조성물
|
|
US9441206B2
(en)
|
2011-10-28 |
2016-09-13 |
The University Of North Carolina At Chapel Hill |
Cell line for production of adeno-associated virus
|
|
WO2013074916A1
(en)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
UA115772C2
(uk)
|
2011-12-16 |
2017-12-26 |
Таргітджин Байотекнолоджиз Лтд |
Композиція програмованого нуклеопротеїнового молекулярного комплексу і спосіб модифікування заданої послідовності нуклеїнової кислоти-мішені
|
|
WO2013096955A1
(en)
|
2011-12-23 |
2013-06-27 |
Case Western Reserve University |
Targeted gene modification using hybrid recombinant adeno-associated virus
|
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
|
WO2013141680A1
(en)
|
2012-03-20 |
2013-09-26 |
Vilnius University |
RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
|
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
|
AU2013266421B2
(en)
|
2012-05-22 |
2017-06-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Murine anti-NY-ESO-1 T cell receptors
|
|
MY189533A
(en)
|
2012-05-25 |
2022-02-16 |
Univ California |
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
|
|
US20150017136A1
(en)
|
2013-07-15 |
2015-01-15 |
Cellectis |
Methods for engineering allogeneic and highly active t cell for immunotherapy
|
|
CN111676196A
(zh)
|
2012-05-25 |
2020-09-18 |
塞勒克提斯公司 |
工程化异体和免疫抑制耐受性t细胞的方法
|
|
US9969696B2
(en)
|
2012-07-04 |
2018-05-15 |
Indian Institute Of Science |
Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
|
|
KR20230065381A
(ko)
|
2012-07-25 |
2023-05-11 |
더 브로드 인스티튜트, 인코퍼레이티드 |
유도 ｄｎａ 결합 단백질 및 게놈 교란 도구 및 이의 적용
|
|
HK1207111A1
(en)
|
2012-08-03 |
2016-01-22 |
加利福尼亚大学董事会 |
Methods and compositions for controlling gene expression by rna processing
|
|
IL293944A
(en)
|
2012-08-20 |
2022-08-01 |
Hutchinson Fred Cancer Res |
Method and preparations for cellular immunotherapy
|
|
ES2824024T3
(es)
|
2012-10-10 |
2021-05-11 |
Sangamo Therapeutics Inc |
Compuestos modificadores de células T y usos de los mismos
|
|
US20140113375A1
(en)
|
2012-10-21 |
2014-04-24 |
Lixin Liu |
Transient Expression And Reverse Transcription Aided Genome Alteration System
|
|
WO2014065596A1
(en)
|
2012-10-23 |
2014-05-01 |
Toolgen Incorporated |
Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
|
|
GB2508414A
(en)
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
AU2013355214B2
(en)
|
2012-12-06 |
2017-06-15 |
Sigma-Aldrich Co. Llc |
Crispr-based genome modification and regulation
|
|
WO2014093694A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
|
|
DK2921557T3
(en)
|
2012-12-12 |
2016-11-07 |
Broad Inst Inc |
Design of systems, methods and optimized sequence manipulation guide compositions
|
|
CN105209621B
(zh)
|
2012-12-12 |
2021-05-25 |
布罗德研究所有限公司 |
对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
|
|
CN119752887A
(zh)
|
2012-12-12 |
2025-04-04 |
布罗德研究所有限公司 |
用于序列操纵的系统、方法和优化的指导组合物的工程化
|
|
CA2894668A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas systems and methods for altering expression of gene products in eukaryotic cells
|
|
EP2931898B1
(en)
|
2012-12-12 |
2016-03-09 |
The Broad Institute, Inc. |
Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
|
|
EP4299741A3
(en)
|
2012-12-12 |
2024-02-28 |
The Broad Institute, Inc. |
Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
|
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
|
WO2014093709A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
|
EP4481048A3
(en)
|
2012-12-17 |
2025-02-26 |
President and Fellows of Harvard College |
Rna-guided human genome engineering
|
|
WO2014127287A1
(en)
|
2013-02-14 |
2014-08-21 |
Massachusetts Institute Of Technology |
Method for in vivo tergated mutagenesis
|
|
US10227610B2
(en)
|
2013-02-25 |
2019-03-12 |
Sangamo Therapeutics, Inc. |
Methods and compositions for enhancing nuclease-mediated gene disruption
|
|
KR102363191B1
(ko)
|
2013-02-26 |
2022-02-17 |
메모리얼 슬로안 케터링 캔서 센터 |
면역치료용 조성물 및 방법
|
|
US9393257B2
(en)
|
2013-03-01 |
2016-07-19 |
Regents Of The University Of Minnesota |
TALEN-based gene correction
|
|
US20160138027A1
(en)
|
2013-03-14 |
2016-05-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of diseases and conditions associated with dysregulation of mammalian target of rapamycin complex 1 (mtorc1)
|
|
ES2667209T3
(es)
|
2013-03-14 |
2018-05-10 |
Asklepios Biopharmaceutical, Inc. |
Genes del receptor-1 de VEGF soluble modificado y vectores para terapia génica
|
|
WO2014150624A1
(en)
|
2013-03-14 |
2014-09-25 |
Caribou Biosciences, Inc. |
Compositions and methods of nucleic acid-targeting nucleic acids
|
|
US20140271550A1
(en)
*
|
2013-03-14 |
2014-09-18 |
The Trustees Of The University Of Pennsylvania |
Constructs and Methods for Delivering Molecules via Viral Vectors with Blunted Innate Immune Responses
|
|
KR102210319B1
(ko)
|
2013-03-15 |
2021-02-01 |
더 제너럴 하스피탈 코포레이션 |
특정 게놈 좌위에 대한 유전적 및 후성적 조절 단백질의 rna-안내 표적화
|
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
|
US20140273230A1
(en)
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
|
WO2014165825A2
(en)
|
2013-04-04 |
2014-10-09 |
President And Fellows Of Harvard College |
Therapeutic uses of genome editing with crispr/cas systems
|
|
EP2983707B1
(en)
*
|
2013-04-08 |
2019-06-12 |
University of Iowa Research Foundation |
Chimeric adeno-associated virus/ bocavirus parvovirus vector
|
|
US11311575B2
(en)
|
2013-05-13 |
2022-04-26 |
Cellectis |
Methods for engineering highly active T cell for immunotherapy
|
|
AU2014266833B2
(en)
|
2013-05-13 |
2020-07-02 |
Cellectis |
Methods for engineering highly active T cell for immunotherapy
|
|
AU2014265331B2
(en)
|
2013-05-15 |
2019-12-05 |
Sangamo Therapeutics, Inc. |
Methods and compositions for treatment of a genetic condition
|
|
EP3309248B1
(en)
|
2013-05-29 |
2021-06-09 |
Cellectis |
Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
|
|
ES2883131T3
(es)
|
2013-05-29 |
2021-12-07 |
Cellectis |
Métodos para la modificación de células T para inmunoterapia utilizando el sistema de nucleasa CAS guiado por ARN
|
|
US20160122774A1
(en)
|
2013-05-29 |
2016-05-05 |
Cellectis |
A method for producing precise dna cleavage using cas9 nickase activity
|
|
JP6195474B2
(ja)
|
2013-05-31 |
2017-09-13 |
ギガフォトン株式会社 |
極端紫外光生成装置及び極端紫外光生成システムにおけるレーザシステムの制御方法
|
|
DK3011029T3
(da)
|
2013-06-17 |
2020-03-16 |
Broad Inst Inc |
Administration, modificering og optimering af tandem-guidesystemer, fremgangsmåder og sammensætninger til sekvensmanipulering
|
|
ES2767318T3
(es)
|
2013-06-17 |
2020-06-17 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas, métodos y composiciones para generar modelos y actuar sobre enfermedades y trastornos de células posmitóticas
|
|
WO2014204727A1
(en)
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
|
|
EP3011031B1
(en)
|
2013-06-17 |
2020-09-30 |
The Broad Institute Inc. |
Delivery and use of the crispr-cas systems, vectors and compositions for hepatic targeting and therapy
|
|
EP3011035B1
(en)
|
2013-06-17 |
2020-05-13 |
The Broad Institute, Inc. |
Assay for quantitative evaluation of target site cleavage by one or more crispr-cas guide sequences
|
|
KR20160056869A
(ko)
|
2013-06-17 |
2016-05-20 |
더 브로드 인스티튜트, 인코퍼레이티드 |
바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용
|
|
CN105492611A
(zh)
|
2013-06-17 |
2016-04-13 |
布罗德研究所有限公司 |
用于序列操纵的优化的crispr-cas双切口酶系统、方法以及组合物
|
|
JP2016528890A
(ja)
|
2013-07-09 |
2016-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ＣＲＩＳＰＲ／Ｃａｓ系を用いるゲノム編集の治療用の使用
|
|
RU2704981C2
(ru)
|
2013-07-10 |
2019-11-01 |
Президент Энд Фэллоуз Оф Харвард Коллидж |
Ортогональные белки cas9 для рнк-направляемой регуляции и редактирования генов
|
|
KR102445330B1
(ko)
|
2013-07-12 |
2022-09-19 |
더 칠드런스 호스피탈 오브 필라델피아 |
Ａａｖ 벡터 및 항―ａａｖ （아데노-관련 바이러스） 중화 항체에 대한 검정
|
|
WO2015006774A2
(en)
|
2013-07-12 |
2015-01-15 |
Oms Investments, Inc. |
Plants comprising events pp009-401, pp009-415, and pp009-469, compositions, sequences, and methods for detection thereof
|
|
US11306328B2
(en)
|
2013-07-26 |
2022-04-19 |
President And Fellows Of Harvard College |
Genome engineering
|
|
US20150044772A1
(en)
|
2013-08-09 |
2015-02-12 |
Sage Labs, Inc. |
Crispr/cas system-based novel fusion protein and its applications in genome editing
|
|
US20160208272A1
(en)
|
2013-08-22 |
2016-07-21 |
E. I. Du Pont De Nemours And Company |
Plant genome modification using guide rna/cas endonuclease systems and methods of use
|
|
WO2015048577A2
(en)
|
2013-09-27 |
2015-04-02 |
Editas Medicine, Inc. |
Crispr-related methods and compositions
|
|
WO2015048690A1
(en)
|
2013-09-27 |
2015-04-02 |
The Regents Of The University Of California |
Optimized small guide rnas and methods of use
|
|
US20150098954A1
(en)
|
2013-10-08 |
2015-04-09 |
Elwha Llc |
Compositions and Methods Related to CRISPR Targeting
|
|
DE102013111099B4
(de)
|
2013-10-08 |
2023-11-30 |
Eberhard Karls Universität Tübingen Medizinische Fakultät |
Permanente Genkorrektur mittels nukleotidmodifizierter messenger RNA
|
|
CN104592364B
(zh)
*
|
2013-10-30 |
2018-05-01 |
北京大学 |
定点突变和定点修饰的腺相关病毒、其制备方法及应用
|
|
PT3066201T
(pt)
|
2013-11-07 |
2018-06-04 |
Massachusetts Inst Technology |
Métodos e composições relacionadas com crispr com arng reguladores
|
|
EP3760719A1
(en)
|
2013-11-18 |
2021-01-06 |
CRISPR Therapeutics AG |
Crispr-cas system materials and methods
|
|
US10787684B2
(en)
|
2013-11-19 |
2020-09-29 |
President And Fellows Of Harvard College |
Large gene excision and insertion
|
|
WO2015079057A2
(en)
|
2013-11-28 |
2015-06-04 |
Haplogen Genomics Gmbh |
Somatic haploid human cell line
|
|
JP6772062B2
(ja)
|
2013-12-02 |
2020-10-21 |
フィオ ファーマシューティカルズ コーポレーションＰｈｉｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐ． |
癌の免疫療法
|
|
WO2015089419A2
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components
|
|
US9068179B1
(en)
|
2013-12-12 |
2015-06-30 |
President And Fellows Of Harvard College |
Methods for correcting presenilin point mutations
|
|
CN103820454B
(zh)
|
2014-03-04 |
2016-03-30 |
上海金卫生物技术有限公司 |
CRISPR-Cas9特异性敲除人PD1基因的方法以及用于特异性靶向PD1基因的sgRNA
|
|
KR102228828B1
(ko)
|
2014-03-11 |
2021-03-16 |
셀렉티스 |
동종이형 이식에 양립성인 t-세포들을 만들어내는 방법
|
|
EP3593812A3
(en)
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Treatment of cancer using chimeric antigen receptor
|
|
CA2943389C
(en)
|
2014-03-20 |
2023-10-31 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Tumor-infiltrating lymphocytes for adoptive cell therapy
|
|
WO2015148454A1
(en)
|
2014-03-28 |
2015-10-01 |
Asklepios Biopharmaceutical, Inc. |
Optimized and modified factor viii genes for gene therapy
|
|
US11439712B2
(en)
|
2014-04-08 |
2022-09-13 |
North Carolina State University |
Methods and compositions for RNA-directed repression of transcription using CRISPR-associated genes
|
|
WO2015157534A1
(en)
|
2014-04-10 |
2015-10-15 |
The Regents Of The University Of California |
Methods and compositions for using argonaute to modify a single stranded target nucleic acid
|
|
SG10201809157VA
(en)
|
2014-04-18 |
2018-11-29 |
Editas Medicine Inc |
Crispr-cas-related methods, compositions and components for cancer immunotherapy
|
|
CN106459917B
(zh)
|
2014-04-23 |
2021-03-09 |
朱诺治疗学股份有限公司 |
分离、培养和遗传工程改造用于过继治疗的免疫细胞群的方法
|
|
WO2015188065A1
(en)
|
2014-06-05 |
2015-12-10 |
Sangamo Biosciences, Inc. |
Methods and compositions for nuclease design
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
WO2015188228A1
(en)
|
2014-06-10 |
2015-12-17 |
Monash University |
Method of producing leukocytes using ptpn2 inhibition for adoptive cell transfer
|
|
WO2015191693A2
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
TWI530276B
(zh)
|
2014-07-08 |
2016-04-21 |
原相科技股份有限公司 |
具去噪功能之生理偵測模組及其生理偵測方法
|
|
KR20170032406A
(ko)
|
2014-07-15 |
2017-03-22 |
주노 쎄러퓨티크스 인코퍼레이티드 |
입양 세포 치료를 위한 조작된 세포
|
|
KR102630014B1
(ko)
|
2014-10-01 |
2024-01-25 |
더 제너럴 하스피탈 코포레이션 |
뉴클레아제-유도 상동성-지정 복구의 효율 증가 방법
|
|
US20170218042A1
(en)
|
2014-10-02 |
2017-08-03 |
The United State of America, as represented by the Secretary, Department of Health and Human Service |
Methods of isolating t cell receptors having antigenic specificity for a cancer-specific mutation
|
|
AU2015330699B2
(en)
|
2014-10-10 |
2021-12-02 |
Editas Medicine, Inc. |
Compositions and methods for promoting homology directed repair
|
|
KR20170075013A
(ko)
|
2014-10-31 |
2017-06-30 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Cart 세포에서 유전자 발현의 변경 및 그의 용도
|
|
EP4400584A3
(en)
|
2014-12-03 |
2024-10-16 |
Agilent Technologies, Inc. |
Guide rna with chemical modifications
|
|
CA2972454C
(en)
|
2014-12-31 |
2024-09-10 |
Viridos, Inc. |
Compositions and methods for high efficiency in in vivo genome editing
|
|
EP3242938B1
(en)
|
2015-01-09 |
2020-01-08 |
Bio-Rad Laboratories, Inc. |
Detection of genome editing
|
|
WO2016115326A1
(en)
|
2015-01-15 |
2016-07-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for modulating genome editing
|
|
KR102422108B1
(ko)
|
2015-01-20 |
2022-07-19 |
삼성디스플레이 주식회사 |
유기 발광 표시 장치
|
|
WO2016133779A1
(en)
|
2015-02-16 |
2016-08-25 |
The Trustees Of The University Of Pennsylvania |
A fully-human t cell receptor specific for the 369-377 epitope derived from the her2/neu (erbb2) receptor protein
|
|
BR112017020750A2
(pt)
|
2015-03-27 |
2018-06-26 |
Harvard College |
células t modificadas e métodos de produção e utilização das mesmas
|
|
GB201508026D0
(en)
*
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
EP3294343A4
(en)
|
2015-05-13 |
2018-09-26 |
Seattle Children's Hospital, dba Seattle Children's Research Institute |
Enhancing endonuclease based gene editing in primary cells
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
AU2016291778B2
(en)
*
|
2015-07-13 |
2021-05-06 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
WO2017023803A1
(en)
|
2015-07-31 |
2017-02-09 |
Regents Of The University Of Minnesota |
Modified cells and methods of therapy
|
|
US10556940B2
(en)
|
2015-09-15 |
2020-02-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
T cell receptors recognizing HLA-Cw8 restricted mutated KRAS
|
|
WO2017053729A1
(en)
|
2015-09-25 |
2017-03-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nuclease-mediated genome editing of primary cells and enrichment thereof
|
|
WO2017100674A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav1
|
|
EP3389695A4
(en)
|
2015-12-16 |
2019-10-09 |
The Walter and Eliza Hall Institute of Medical Research |
INHIBITION OF CYTOKININDUCED SH2 PROTEIN IN NK CELLS
|
|
US9570114B1
(en)
|
2016-01-15 |
2017-02-14 |
HGST Netherlands B.V. |
Laminated film-packed hard disk drive for hermetic sealing
|
|
US11746349B2
(en)
|
2016-02-09 |
2023-09-05 |
President And Fellows Of Harvard College |
DNA-guided gene editing and regulation
|
|
AU2017248656B2
(en)
*
|
2016-04-15 |
2023-07-27 |
The Trustees Of The University Of Pennsylvania |
Novel AAV8 mutant capsids and compositions containing same
|
|
AU2017296236A1
(en)
*
|
2016-07-15 |
2019-01-03 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors and methods for use
|
|
GB2573664B
(en)
*
|
2016-10-27 |
2022-09-28 |
Intima Bioscience Inc |
Viral methods of T cell therapy
|
|
AU2017378191A1
(en)
|
2016-12-16 |
2019-07-04 |
Uniqure Ip B.V. |
Immunoadsorption
|
|
US10550405B2
(en)
|
2017-03-15 |
2020-02-04 |
The University Of North Carolina At Chapel Hill |
Rational polyploid adeno-associated virus vectors and methods of making and using the same
|
|
CN110770346B
(zh)
*
|
2017-03-15 |
2024-01-12 |
北卡罗来纳-查佩尔山大学 |
多倍体腺相关病毒载体及其制备和使用方法
|
|
US20200370039A1
(en)
*
|
2017-04-11 |
2020-11-26 |
Ruprecht-Karls-Universitat Heidelberg |
Adeno-associated virus library
|
|
JP2020530307A
(ja)
|
2017-06-30 |
2020-10-22 |
インティマ・バイオサイエンス，インコーポレーテッド |
遺伝子治療のためのアデノ随伴ウイルスベクター
|
|
KR20250096876A
(ko)
|
2017-07-31 |
2025-06-27 |
리플렉션 바이오테크놀러지스 리미티드 |
안과 질환을 위한 세포 모델 및 치료요법
|
|
US11760987B2
(en)
|
2017-09-07 |
2023-09-19 |
The Regents Of The University Of California |
Compositions and methods for the treatment or prevention of heart failure
|
|
WO2019051278A1
(en)
|
2017-09-07 |
2019-03-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
NUCLEASE SYSTEMS FOR GENETIC ENGINEERING
|
|
JP7389040B2
(ja)
*
|
2018-01-17 |
2023-11-29 |
メイラジーティーエックス・ユーケー・ザ・セカンド・リミテッド |
遺伝子治療のための修飾ｒＡＡＶキャプシドタンパク質
|